Highlights for September 2016
- GSK sells anaesthesia portfolio to Aspen for USD 201 million plus milestones of up to USD 112 million
- Sun Pharma partners Mitsubishi Tanabe to sell 14 prescription brands in Japan
- Agilent Technologies and Burning Rock partner on Molecular Diagnostics
- Allergan to acquire Tobira Therapeutics expanding global GI R&D pipeline and taking a leading R&D position in NASH
- Sun among bidders for Bayer’s dermatology brands
- Zydus Cadila, Takeda to co-develop vaccine for chikungunya
- Syngene buys Strand's Systems Biology and Pharma Services
- Piramal Enterprises to buy OTC business of Morepen Laboratories
- Glenmark inks deal with US firm to develop cancer drug
- Cyagen Biosciences and Vivo Bio Tech partner to provide easy access to Genomic Technologies
- Allergan Acquires RetroSense Therapeutics adding First-In-Class Technology to Company's Innovative Eye Care Pipeline
For more such news and updates, please join our Group "Global Life Science Business Partnering" on LinkedIn.
Based on feedback from some of our readers, we have changed the Name and Theme of our monthly Newsletter, to reflect global deals, also that is our renewed focus.
- Name: Global Life Science Business Partnering
- Theme: Monthly updates focusing on Deals / JVs, M&As, Out/In Licensing (Formulations, OTC Products, Patents) where Pharma, Biotech, and Medical Devices companies are involved. Deals above USD 2 billion will be excluded as everyone would know about them anyways.